Mark Stahl

Mark Stahl currently serves as the Executive Director of Clinical Development at Insmed Incorporated, a position held since February 2024. Prior to this role, Mark held several significant positions in the field of clinical development, including Senior Director at Avidity Biosciences, Inc. and Director at Neurocrine Biosciences. Mark's academic background includes serving as an Assistant Professor at Penn State Milton S. Hershey Medical Center, where research focused on neurodegeneration and movement disorders, alongside providing clinical care for neurology patients. Mark completed neurology residency and a research fellowship in movement disorders at UCLA Health. Educational qualifications include a Doctor of Philosophy and a Doctor of Medicine from Albert Einstein College of Medicine, as well as a Bachelor of Arts in Biology from The Johns Hopkins University.